PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 14677273

Pellet coating by air suspension technique using a mini-model coating unit.

M Ganesan·T K Pal·M Jayakumar
View original source ↗Export metadata ↓

Abstract

Air suspension coating is widely used in the pharmaceutical industry, as an attractive alternative to pan coating in that it can successfully coat small particles, pellets and tablets irrespective of size or shape with a wide variety of coating materials. The commercially available air suspension coating equipments require at least one kilogram of material for optimum efficiency of their working. Therefore, it is felt that there is a potential need for a small, compact air suspension coating instrument, which can work with gram quantities of material. The main objective of the present work is to design and evaluate a laboratory model top spray air suspension coating instrument. The performance of the instrument was evaluated for both, drug loading on to non-pareil pellets and coating of drug-loaded pellets. Terbutaline sulphate was selected as model drug, while Surelease (aqueous polymeric dispersion of ethyl cellulose) as representative coating material. The drug loading efficiency of the instrument was found to be around 82% with a pellet load of 10 g. The drug loading efficiency was found to be satisfactory and reproducible. Scanning electron micrographs of coated pellets indicated that coating was homogenous and uniform around the pellets. The maximum deviations observed in the in vitro drug release studies were +/- 2.7397% of the mean percent quantity of drug released, which is low enough for the coating to be considered uniform and reproducible. Reproducibility of the coating process was further confirmed by determining the 95% confidence interval for average difference in cumulative percentage drug release between two runs of each batch, which was found to be less than 5% set as the maximum allowable difference. The release data obtained were found to show best fit with first order kinetic model. A significant influence of coating thickness on the drug release rate was observed. From the results and observations of this work, it may be concluded that the mini-model air suspension coating instrument designed, may be a useful piece of equipment for preparing coated multiparticulate dosage forms in small quantities for sustained drug delivery, especially in research works.

Explore related subjects

Bronchodilator AgentsCelluloseColloidsDrug CompoundingExcipientsParticle SizeReproducibility of ResultsTerbutalineJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Ganesan, T K Pal, M Jayakumar. 2003. Pellet coating by air suspension technique using a mini-model coating unit.. https://pubmed.ncbi.nlm.nih.gov/14677273/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Physical stability enhancement of theophylline via cocrystallization.

The crystal form adopted by the respiratory drug theophylline was modified using a crystal engineering strategy in order to search for a solid material with improved physical stability. Cocrystals, also referred to as crystalline molecular complexes, were prepared with theophylline and one of several dicarboxylic acids. Four cocrystals of theophylline are reported, one each with oxalic, malonic, maleic and glutaric acids. Crystal structures were obtained for each cocrystal material, allowing an examination of the hydrogen bonding and crystal packing features. The cocrystal design scheme was partly based upon a series of recently reported cocrystals of the molecular analogue, caffeine, and comparisons in packing features are drawn between the two cocrystal series. The theophylline cocrystals were subjected to relative humidity challenges in order to assess their stability in relation to crystalline theophylline anhydrate and the equivalent caffeine cocrystals. None of the cocrystals in this study converted into a hydrated cocrystal upon storage at high relative humidity. Furthermore, the theophylline:oxalic acid cocrystal demonstrated superior humidity stability to theophylline anhydrate under the conditions examined, while the other cocrystals appeared to offer comparable stability to that of theophylline anhydrate. The results demonstrate the feasibility of pharmaceutical cocrystal design based upon the crystallization preferences of a molecular analogue, and furthermore show that avoidance of hydrate formation and improvement in physical stability is possible via pharmaceutical cocrystallization.

Bronchodilator Agents↗
PubMed2006

The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.

In this study, the effect of lactose carrier surface treatment on drug particle detachment during inhalation has been investigated. Crystals of marketed brands of alpha lactose monohydrate brands normally exhibit a certain surface rugosity and contain natural fines and impurities on their surface, which influence the drug-to-carrier interaction in adhesive mixtures for inhalation. Submersion treatment may change these surface characteristics. Two different sieve fractions (63-90 and 250-355microm) were submerged in mixtures of ethanol and water (96 and 80% v/v, respectively). Microscopic observation and laser diffraction analysis revealed that neither the shape nor the size of the carrier particles was changed by the submersion treatment. However, the specific surface area and the amount of impurities appeared to decrease substantially after submersion, and the magnitude of the decrease was different for the different ethanol-water mixtures. The reduction in specific surface area was attributed particularly to the removal of the adhering lactose fines from the carrier surface. Mixtures with budesonide (in a wide range of carrier payloads) were prepared before and after treatment. Drug particle detachment from the various mixtures was studied with a sieve test and with a cascade impactor analysis at 30 and 60l/min. Two different types of inhalers were used, one generating lift- and drag-forces (ISF inhaler) and one generating inertial forces (test inhaler), respectively. The cascade impactor and sieve test experiments showed that an increase in carrier surface smoothness results in a reduced drug particle detachment during inhalation, which was independent of the type of inhaler used. This reduction could be attributed to the removal of the adhering lactose fines which may provide shelter for the drug particles from press-on forces during mixing.

Bronchodilator Agents↗